Clinical validation of the avidin/indium-111 biotin approach for imaging infection/inflammation in orthopaedic patients

European Journal of Nuclear Medicine

Volumn 26, Issue 6, 1999, Pages 606-614

  Lazzeri, Elena ^a   Manca, Mario ^a   Molea, Nicola ^a,d   Marchetti, Stefano ^a   Consoli, Vincenzo ^a   Bodei, Lisa ^a   Bianchi, R ^a   Chinol, Marco ^b   Paganelli, Giovanni ^b   Mariani, Giuliano ^c  

^a UNIVERSITY OF PISA   (Italy)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d Town Hospital   (Italy)

Author keywords

Avidin streptavidin; Indium III biotin; Inflammation infection; Orthopaedic patients; Scintigraphic imaging

Indexed keywords

AVIDIN; BIOTIN; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; INDIUM 111; STREPTAVIDIN;

ADULT; AGED; ARTICLE; BONE LESION; CLINICAL TRIAL; COMPARATIVE STUDY; FEMALE; HUMAN; INFECTION; INFLAMMATION; INTRAVENOUS DRUG ADMINISTRATION; JOINT PROSTHESIS; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL HAZARD; ORTHOPEDICS; OSTEOMYELITIS; SCINTIGRAPHY; STATISTICAL ANALYSIS; VALIDATION PROCESS;

AVIDIN; BIOTIN; DISCITIS; FEMALE; HUMANS; INDIUM RADIOISOTOPES; LEUKOCYTES; MALE; MIDDLE AGED; OSTEOMYELITIS; PREDICTIVE VALUE OF TESTS; PROSTHESIS-RELATED INFECTIONS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M EXAMETAZIME;

EID: 0033059535     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050428     Document Type: Article

References (56)

1. Edwards CL, Hayes RL. Tumor scanning with gallium citrate. J Nucl Med 1969; 10: 103-105.
2. 67Ga citrate [abstract]. J Nucl Med 1971; 12: 338.
3. Lavender JP, Lowe J, Barker JR. Gallium-67 citrate scanning in neoplastic and inflammatory lesions. Br J Radiol 1971; 44: 361-366.
4. Seabold JE, Palestro CJ, Brown ML, et al. Procedure guideline for gallium scintigraphy in inflammation. J Nucl Med 1997; 38: 994-997.
5. Maurer AH, Chen DCP, Camargo EE, Wong DF, Wagner HN Jr, Alderson PO. Utility of three-phase skeletal scintigraphy in suspected osteomyelitis: concise communication. J Nucl Med 1981; 22: 941-949.
6. Alazraki N, Dries D, Datz F, Lawrence P, Greenberg E, Taylor A Jr. Value of a 24-hour image (four-phase bone scan) in assessing osteomyelitis in patients with peripheral vascular disease. J Nucl Med 1985; 26: 711-717.
7. McAfee JG, Thakur ML. Survey of radioactive agents for in vitro labelling of phagocytic leucocytes. I. Soluble agents. J Nucl Med 1976; 17: 480-487.
8. Thakur ML, Coleman RE, Welch MJ. Indium-111 labelled leucocytes for the localization of abscesses: preparation, analysis, tissue distribution and comparison with gallium-67 citrate in dogs. J Lab Clin Med 1977; 89: 217-228.
9. Thakur ML, Lavender JP, Arrot RN, et al. Indium-111 labelled autologous leucocytes in man. J Nucl Med 1977; 18: 1014-1021.
10. 111In-tropolonate. Br J Radiol 1982; 55: 247-249.
11. Peters AM, Danpure NJ, Osman S, et al. Preliminary clinical experience with Tc-99m-HMPAO for labelling leucocytes and imaging infection. Lancet 1986; II: 945-949.
12. Becker W, Schomann E, Fischbach W, Borner WB, Gruner K. Comparison of Tc-99m-HMPAO and In-111-oxine labelled granulocytes in man: first clinical results. Nucl Med Commun 1988; 9: 435-447.
13. 99mTc-HMPAO-leukocytes for imaging infection. Semin Nucl Med 1994; 24: 110-127.
14. Seabold JE, Forstrom LA, Schauwecker DS, et al. Procedure guideline for indium-111-leucocyte scintigraphy for suspected infection/inflammation. J Nucl Med 1997; 38: 997-1001.
15. Schrijver MD, Streule K, Senekowitsch R, Fridrich R. Scintigraphy of inflammation with nanometer-size colloidal tracers. Nucl Med Commun 1987; 8: 895-908.
16. Flivik G, Sloth M, Rydholm U, Herrlin K, Lidgren L. Technetium-99m-nanocolloid scintigraphy in orthopaedic infections: a comparison with In-111-labelled leucocytes. J Nucl Med 1993; 34: 1646-1650.
17. Fischman AJ, Rubin RH, Khaw BA, et al. Detection of acute inflammation with In-111-labelled nonspecific IgG. Semin Nucl Med 1988; 30: 335-344.
18. 111In-labelled human immunoglobulin G scan for detection of focal vascular graft infection. J Vasc Surg 1989; 10: 20-28.
19. 111In-labelled nonspecific immunoglobulin scanning in the detection of focal infection. N Engl J Med 1989; 321: 935-940.
20. Rubin RH, Fischman AJ, Needleman M, et al. Radiolabelled nonspecific human immunoglobulin in the detection of focal inflammation by scintigraphy: comparison with gallium-67 citrate and technetium-99m-labelled albumin. J Nucl Med 1989; 30: 385-389.
21. Fischman AJ, Rubin RH, White AA, et al. Localization of Fc and Fab fragments of nonspecific polyclonal IgG at focal sites of inflammation. J Nucl Med 1990; 31: 1199-1205.
22. Oyen WJG, Claessens RAMJ, van der Meer JWM, Rubin RH, Strauss HW, Corstens FHM. Indium-111-labelled human nonspecific immunoglobulin G: a new radiopharmaceutical for imaging infectious and inflammatory foci. Clin Infect Dis 1992; 14: 1110-1118.
23. Andres RY, Schubiger PA, Tiefenauer L, et al. Immunoscintigraphic localization of inflammatory lesions: concept, radiolabelling and in vitro testing of a granulocyte specific antibody. Eur J Nucl Med 1988; 13: 582-586.
24. 99mTc anti-NCA monoclonal antibodies for imaging inflammation. Eur J Nucl Med 1988; 14: 353-367.
25. Joseph A, Hoffken H, Bosslet K, Schorlemmer HU. Imaging of inflammation with granulocytes labelled in vivo. Nucl Med Commun 1988; 9: 763-769.
26. Thakur ML, Richard MF, White FW. Monoclonal antibodies as agents for selective radiolabelling of human neutrofils. J Nucl Med 1988; 29: 1817-1825.
27. 99mTc-labelled monoclonal antigranulocyte antibody (Mab BW 250/183). J Nucl Med 1990; 31: 417-423.
28. Reuland P, Winkler KH, Heuchert T, et al. Detection of infection in postoperative orthopaedic patients with technetium-99m-labelled monoclonal antibodies against granulocytes. J Nucl Med 1991; 32: 2209-2214.
29. Sciuk J, Brandau W, Vollet B, et al. Comparison of technetium 99m polyclonal human immunoglobulin and technetium 99m monoclonal antibodies for imaging chronic osteomyelitis. First clinical results. Eur J Nucl Med 1991; 18: 401-407.
30. Hotze AL, Brieke B, Overbeck B, et al. Technetium-99m-labelled anti-granulocyte antibodies in suspected bone infections. J Nucl Med 1992; 33: 526-531.
31. Becker W, Bair J, Behr T, et al. Detection of soft-tissue infections and ostemyelitis using a technetium-99m-labelled anti-granulocyte monoclonal antibody fragment. J Nucl Med 1994; 35: 1436-1443.
32. Becker W, Palestro CJ, Winship J, et al. Rapid imaging of infections with a monoclonal antibody fragment (LeukoScan). Clin Orthop 1996; 329: 263-272.
33. Barron BJ, Robins DB, Lamki LM, Daniels W, Chopra L, Black CT. Intussusception secondary to Meckel's diverticulum detection with Tc-99m monoclonal antibodies to granulocytes (LeukoScan). Clin Nucl Med 1996; 21: 834-837.
34. Hakki S, Harwood SJ, Morissey MA, Camblin JG, Laven DL, Webster WB Jr. Comparative study of monoclonal antibody scan in diagnosing orthopaedic infection. Clin Orthoped 1997; 335: 275-285.
35. 99mTc infecton imaging with white-cell imaging in the evaluation of bacterial infection. Lancet 1996; 347: 233-235.
36. Britton KE, Vinjamuri S, Hall AV, et al. Clinical evaluation of technetium-99m Infecton for the localisation of bacterial infection. Eur J Nucl Med 1997; 24: 553-556.
37. Rusckowski M, Paganelli G, Hnatowich DJ, Virzi F, Fogarasi M, Fazio F. Imaging infection/inflammation in patients with streptavidin and radiolabelled biotin: preliminary observations [abstract]. J Nucl Med 1992; 33: 926.
38. Rusckowski M, Fritz B, Hnatowich DJ. Localization of infection using streptavidin and biotin: an alternative to nonspecific polyclonal immunoglobulin. J Nucl Med 1992; 33: 1810-1815.
39. 111In-labelled biotin scan: a new radioisotopic method for localising vascular graft infection. Eur J Vasc Endovasc Surg 1995; 10: 405-414.
40. Samuel A, Paganelli G, Chiesa R, et al. Detection of prosthetic vascular graft infection using avidin/indium-111-biotin scintigraphy. J Nucl Med 1996; 37: 55-61.
41. Rusckowski M, Paganelli G, Hnatowich DJ, et al. Imaging osteomyelitis with streptavidin and indium-111-labelled biotin. J Nucl Med 1996; 37: 1655-1662.
42. van der Laken CJ, Boerman OC, Oyen WJG, et al. Technetium-99m-labelled chemotactic peptides in acute infection and sterile inflammation. J Nucl Med 1997; 38: 1310-1315.
43. Babich JW, Tompkins RG, Graham W, Barrow SA, Fischman AJ. Localization of radiolabelled chemotactic peptide at focal sites of Escherichia coli infection in rabbits: evidence for a receptor-specific mechanism. J Nucl Med 1997; 38: 1316-1322.
44. van der Laken CJ, Boerman OC, Oyen WJG, van de Ven MTP, van der Meer JWM, Corstens FHM. Scintigraphic detection of infection and inflammation: new developments with special emphasis on receptor interaction. Eur J Nucl Med 1998; 25: 535-546.
45. Palestro CJ, Kim CK, Swyer AJ, Vallabhajosula S, Goldsmith SJ. Radionuclide diagnosis of vertebral osteomyelitis: indium-111-leucocyte and technetium-99m-methylene diphosphonate bone scintigraphy. J Nucl Med 1991; 32: 1861-1865.
46. Whalen JL, Brown ML, McLeod R, Fitzgerald RH Jr. Limitations of indium leucocyte imaging for the diagnosis of spine infections. Spine 1991; 16: 193-197.
47. Paganelli G, Chinol M, Maggiolo M, et al. The three-step pre-targeting approach reduces the human anti-mouse antibody response in patients submitted to radioimmunoscintigraphy and radioimmunotherapy [letter]. Eur J Nucl Med 1997; 24: 350-351.
48. Datz FL, Seabold JE, Brown ML, et al. Procedure guideline for technetium-99m-HMPAO-labelled leucocyte scintigraphy for suspected infection/inflammation. J Nucl Med 1997; 38: 987-990.
49. 90Y-biotin: dosimetry and pharmacokinetics in cancer patients. Eur J Nucl Med 1999; 26: 110-120.
50. Grana C, Chinol M, Magnani P, et al. In vivo tumour targeting based on the avidin-biotin system. Tumor Targeting 1996; 2: 230-239.
51. Schechter B, Silberman R, Arnon R, et al. Tissue distribution of avidin and streptavidin injected to mice. Effect of avidin carbohydrate, streptavidin truncation and exogenous biotin. Eur J Biochem 1990; 189: 327-331.
52. Wilcheck M, Bayer EA. The avidin-biotin complex in immunology. Immunol Today 1984; 5: 39-43.
53. Gitlin G, Bayer EA, Wilcheck M. Studies on the biotin-binding sites of avidin and streptavidin. Biochem J 1990; 269; 527-530.
54. Chinol M., Casalini P., Maggiolo M., et al. Biochemical modifications of avidin improve pharmacokinetics and biodistribution, and reduce immunogenicity. Br J Cancer 1998; 78: 189-197.
55. Peters AM, Jamar F. The importance of endothelium and interstitial fluid in nuclear medicine. Eur J Nucl Med 1998; 25: 801-815.
56. Shoup TM, Fischman AJ, Jaywook S, Babich JW, Strauss HW, Elmaleh DR. Synthesis of fluorine-18-labelled biotin derivatives: biodistribution and infection localization. J Nucl Med 1994; 35: 1685-1690.